Oxaliplatin in Treating Patients With Metastatic Bladder Cancer

Clinical trial NCT00004203 · COMPLETED

Trial details

NCT number: NCT00004203
Sponsor: University of Chicago
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Transitional Cell Cancer of the Renal Pelvis and Ureter

Start date: 2000-02-01
Primary completion: 2002-02-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.